Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × INDIV × pegfilgrastim × Clear all

Phase

Status

Sponsor Class

OTHER 75 INDUSTRY 46 NETWORK 15 NIH 6 INDIV 1

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Neutropenia 1 Neoplasms 1 Lung Neoplasms 1 Carcinoma, Non-Small-Cell Lung 1

Interventions

Proflavine 3 Microbial Collagenase 2 sargramostim 1 pembrolizumab 1 pegfilgrastim 1 macimorelin 1 keyhole-limpet hemocyanin 1 Sodium Chloride 1 Sirolimus 1 Peptides 1 Monatide (IMS 3015) 1 Ipilimumab 1 Gemcitabine 1 Everolimus 1 Bimatoprost 1 Bevacizumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00050674 2012-12-27

Docetaxel and Gemcitabine With Filgrastim-SD/01 Support in Patients With Advanced Non-Small Cell Lung Carcinoma

Schwartzberg, Lee, M.D.

Phase 2 Completed

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Neoplasms, Neutropenia

Data powered by HemOnc (CC BY 4.0) Colophon ⚡